Qiagen N.V. (QIA.DE)
XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
At close: 05:35PM CEST
| Previous Close | 41.88 |
| Open | 41.84 |
| Bid | 41.48 x 48300 |
| Ask | 41.49 x 51100 |
| Day's Range | 41.35 - 41.90 |
| 52 Week Range | 33.75 - 44.81 |
| Volume | |
| Avg. Volume | 624,720 |
| Market Cap | 9.198B |
| Beta (5Y Monthly) | 0.42 |
| PE Ratio (TTM) | 29.61 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.18 (2.94%) |
| Ex-Dividend Date | Jan 30, 2024 |
| 1y Target Est | N/A |
- Zacks
Here's Why Investors Should Retain QIAGEN (QGEN) Stock Now
QIAGEN's (QGEN) solid potential in the NGS platform buoys optimism for investors.
- Zacks
QIAGEN's (QGEN) QCI Interpret Gets European IVDR Certification
QIAGEN's (QGEN) Clinical Insight Interpret is the first NGS interpretation platform approved by IVDR for use in cancer and hereditary applications.
- Zacks
QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus
QIAGEN (QGEN) receives FDA clearance for the QIAstat-Dx respiratory syndromic testing panel for fast and accurate results.
© 2024 Yahoo. All rights reserved.